|
|
|
|
Home
| About
Us
| What's New
| Products & Services
| Prices
/ Ordering
| Technical
Support
| Your
Home
| Contact
Us
|
|
Treat your
cells to LoTox™ - Purified Allergens
with Low Endotoxin Content! |
|
INDOOR Biotechnologies Inc. is delighted to announce that it has recently been awarded a Small Business Innovation and Research Phase II Contract to develop fluorescent multiplex array technology for indoor allergen detection. This technology will make it possible to measure multiple allergens simultaneously in a single dust or air sample. After successfully developing array for five mite and cat allergens as part of Phase I feasibility studies, IBI was awarded the Phase II contract by the U.S. National Institutes of Environmental Health Sciences. The technology will be extended to measure a panel of 10-15 common indoor allergens. The multiplex technology will be jointly developed over two years with Dr. Kerry Oliver of Radix Biosolutions Inc (Austin, TX). Radix is a custom manufacturer of Luminex® xMAP microspheres. The multiplex technology will be a major advance in allergen detection and will facilitate large scale epidemiologic studies on allergen exposure and asthma. |
|
|
|